HH

Harry H. Stine

North America, Iowa, United States, Adel

Description

Harry Stine is synonymous with many titles – innovator, businessman, entrepreneur – but the title holding the most significance to him is fa...

Investor Profile

Harry H. Stine has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Harry H. Stine frequently co-invest with?

Mayo Clinic
North America, Minnesota, United States, Rochester
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Southeast Minnesota Capital Fund
North America, Minnesota, United States, Rochester
Co-Investments: 1
Regeneron
North America, New York, United States, Tarrytown
Co-Investments: 1

What are some of recent deals done by Harry H. Stine?

Vyriad

Rochester, Minnesota, United States

Vyriad is a clinical stage biopharmaceutical company.

Biotechnology
Series BMay 17, 2022
Amount Raised: $29,500,000